Clinical Trials Directory

Trials / Terminated

TerminatedNCT00732628

Evaluating Outcomes in the Placement of Boomerang Percutaneous Device

Technical and Clinical Outcomes Following Placement of Boomerang Percutaneous Closure Device After Cerebral Angiography or Neurointerventional Procedures

Status
Terminated
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Boomerang percutaneous closure device following diagnostic cerebral angiography or neurointerventional procedures. Background: Very few publications have evaluated this relatively novel percutaneous closure device.

Detailed description

The purpose of this study is to document our experiences using the Boomerang closure device. Several different closure devices are used in the department of Radiology. A closure device is something that is placed in the artery in the leg just prior to removing the catheters from your leg at the end of the imaging or treatment procedure that is to be performed in the Department of Radiology. The devices used are all FDA approved. This study will compare the Boomerang device (a newer FDA approved device) to the other older devices currently being used. You may not have the Boomerang device used in your procedure; however, the Boomerang device is used in almost all of our patients undergoing a neuro imaging or treatment procedure. The neuroradiologist will determine which device if any is best for you based on the size of your artery, your medical condition etc. We will only collect data about you and your procedure if the Boomerang device is used.

Conditions

Interventions

TypeNameDescription
DEVICEBoomerang closure deviceUse of percutaneous of Boomerang closure device. Follow up outcomes evaluated after the use of Boomerang closure device.

Timeline

Start date
2008-01-01
Completion
2008-09-01
First posted
2008-08-12
Last updated
2009-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00732628. Inclusion in this directory is not an endorsement.